✨ Free AI Report
Kobayashi Pharmaceutical Co., Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Kobayashi Pharmaceutical Co., Ltd.
Company Research

Kobayashi Pharmaceutical Co., Ltd.: Business Overview, Financials & Competitive Analysis

Kobayashi Pharmaceutical manufactures and sells OTC pharmaceuticals, quasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. Founded in 1886 and headquartered i...

Analyst-debate audio for Kobayashi Pharmaceutical Co., Ltd.

AskCyborg analysts argue the bull and bear cases for Kobayashi Pharmaceutical Co., Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
5/ 10Mixed

Cyborg Score thesis

Established consumer health company with global expansion ambitions, but recent profitability challenges and elevated dividend...

Read the full analyst-debate transcript →
Industry OTC Pharmaceuticals & Consumer Health Products
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest Kobayashi Pharmaceutical Co., Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Kobayashi Pharmaceutical Co., Ltd. Overview

Pro stress-test →

Kobayashi Pharmaceutical manufactures and sells OTC pharmaceuticals, quasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. Founded in 1886 and headquartered in Osaka, Japan, the company has established a diversified consumer health and household products portfolio spanning over a century.

Strategic Profile

Pro stress-test →

The company's strategic focus is on expanding its global presence, leveraging its strong domestic reputation to build brand recognition in international markets. Kobayashi Pharmaceutical is recognized for its innovative approach to product development, regularly introducing new offerings that respond to changing consumer needs.

Competitive Landscape

Pro stress-test →

Kobayashi Pharmaceutical competes in Japan's OTC pharmaceutical and household products market against both established domestic manufacturers and international players. The company's 140-year heritage and brand recognition provide competitive advantages, but it faces pricing pressures and margin compression typical of the consumer health industry.

Industry Context

Kobayashi Pharmaceutical Co., Ltd. operates in OTC Pharmaceuticals & Consumer Health Products.

Key facts

Founded: 1886 · Headquarters: Osaka, Japan · Revenue: ¥53.70B (last quarter), annual estimated ~¥214.8B · Market cap: ¥427.89B-444.1B (~$2.9B-3.0B USD)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Kobayashi Pharmaceutical Co., Ltd..

  • Recent negative net income in latest quarter (-3.15B JPY) indicates operational challenges despite positive prior quarter performance
  • Extremely high dividend payout ratio of 211.46% in 2025 suggests unsustainable current dividend policy
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2024Dropped from S&P Japan Mid Cap 100 index
  • 2025Dividend yield increased to 1.92% with significantly elevated payout ratio of 211.46%
  • +1 moreTrack every material event for Kobayashi Pharmaceutical Co., Ltd. as it happens. Explore monitoring →
Get alerted when Kobayashi Pharmaceutical Co., Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Kobayashi Pharmaceutical Co., Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Kobayashi Pharmaceutical Co., Ltd. operates in OTC Pharmaceuticals & Consumer Health Products. See how the rest of the sector scores on the Cyborg framework.

Browse OTC Pharmaceuticals & Consumer Health Products research →
NEW · MCP server

Ask your AI assistant about Kobayashi Pharmaceutical Co., Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Kobayashi Pharmaceutical Co., Ltd. and its top competitor on Cyborg Score”
“What did Kobayashi Pharmaceutical Co., Ltd. do this quarter?”
“Is Kobayashi Pharmaceutical Co., Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Kobayashi Pharmaceutical Co., Ltd. do?+
Kobayashi Pharmaceutical manufactures and sells OTC pharmaceuticals, quasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. Founded in 1886 and headquartered i...
What is Kobayashi Pharmaceutical Co., Ltd.'s Cyborg Score?+
Kobayashi Pharmaceutical Co., Ltd. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Kobayashi Pharmaceutical Co., Ltd.'s main competitors?+
Named competitors include OTC Pharmaceuticals & Household Products, Air Fresheners & Deodorizers, Sanitary & Daily Necessities. The full competitive landscape is in the AskCyborg report.
How can I get the full Kobayashi Pharmaceutical Co., Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Kobayashi Pharmaceutical Co., Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Kobayashi Pharmaceutical Co., Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual